M
Miren Ettcheto
Researcher at University of Barcelona
Publications - 79
Citations - 3029
Miren Ettcheto is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 22, co-authored 63 publications receiving 1636 citations. Previous affiliations of Miren Ettcheto include University of Coimbra & Rovira i Virgili University.
Papers
More filters
Journal ArticleDOI
Metal-based nanoparticles as antimicrobial agents: an overview.
Elena Sánchez-López,Elena Sánchez-López,Daniela Gomes,Gerard Esteruelas,Lorena Bonilla,Ana López-Machado,Ana López-Machado,Ruth Galindo,Amanda Cano,Amanda Cano,Marta Espina,Miren Ettcheto,Miren Ettcheto,Antoni Camins,Antoni Camins,Amélia M. Silva,Alessandra Durazzo,Antonello Santini,Maria Luisa García,Maria Luisa García,Eliana B. Souto,Eliana B. Souto +21 more
TL;DR: Their added-value in the development of alternative, more effective antibiotics against multi-resistant Gram-negative bacteria has been highlighted and their production methods, physicochemical characterization, and pharmacokinetics are reviewed.
Journal ArticleDOI
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
Jaume Folch,Dmitry Petrov,Miren Ettcheto,Sonia Abad,Elena Sánchez-López,M. Luisa García,Jordi Olloquequi,Carlos Beas-Zarate,Carme Auladell,Antoni Camins +9 more
TL;DR: Fyn kinase blockers masitinib and saracatinib have proven to be efficacious in treating AD symptoms in experimental mouse models of the disease and an alternative strategy centred on the inhibition of the downstream Aβ signalling, particularly at the synapse is suggested.
Journal ArticleDOI
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Amanda Cano,Miren Ettcheto,Jui-Hsien Chang,Emma Barroso,Marta Espina,Britta A. Kühne,Marta Barenys,C. Auladell,Jaume Folch,Eliana B. Souto,Antoni Camins,Patric Turowski,Maria Luisa García +12 more
TL;DR: Oral treatment of APPswe/PS1dE9 mice with EGCG/AA NPs resulted in a marked increase in synapses, as judged by synaptophysin (SYP) expression, and reduction of neuroinflammation as well as amyloid &bgr; (A&b gr;) plaque burden and cortical levels of soluble and insoluble A&b Gr;(1‐42) peptide.
Journal ArticleDOI
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Elena Sánchez-López,Elena Sánchez-López,Miren Ettcheto,Miren Ettcheto,M.A. Egea,Marta Espina,Amanda Cano,Amanda Cano,Ana C. Calpena,Antoni Camins,Antoni Camins,Nuria Carmona,Amélia M. Silva,Eliana B. Souto,Maria Luisa García +14 more
TL;DR: Histological studies confirmed that MEM–PEG–PLGA NPs reduced β-amyloid plaques and the associated inflammation characteristic of Alzheimer’s disease.
Journal ArticleDOI
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.
Jaume Folch,Oriol Busquets,Miren Ettcheto,Elena Sánchez-López,Rubén Darío Castro-Torres,Ester Verdaguer,Maria Luisa García,Jordi Olloquequi,Gemma Casadesus,Carlos Beas-Zarate,Carme Pelegrí,Jordi Vilaplana,Carme Auladell,Antoni Camins +13 more
TL;DR: The data in preclinical studies suggests that MEM has a positive impact on improving AD brain neuropathology, as well as in preventing Aβ production, aggregation, or downstream neurotoxic consequences, in part through the blockade of extrasynaptic NMDAR.